Éteres

5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone is a pharmacological agent that is structurally similar to rapamycin. It has been shown to inhibit the production of creatine kinase in rat liver microsomes and has been used in studies on degenerative diseases. 5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone inhibits the activity of polymerase chain reaction (PCR) by binding to the DNA polymerase and blocking the extension of an oligonucleotide primer. It has also been shown to be toxic to humans, as it can cause fatty acid accumulation and a clinical response. In addition, this drug is enantiopure, meaning that it is composed of only one type of molecule with a specific configuration. The analytical chemistry for this drug includes gas chromatography (GC) and high performance liquid chromatography (HPLC).

3-Bromo-4-methoxycinnamic acid is an organic compound that is used as a reagent, a useful scaffold, and a useful intermediate. It has been shown to be an excellent building block for the synthesis of complex compounds. 3-Bromo-4-methoxycinnamic acid can be used in the production of fine chemicals.